Sandy Wong, MDMyeloma | March 20, 2023
Sandy Wong, MD, explains how clinicians and researchers can help educate others about myeloma.
View More
Leah SherwoodMyeloma | March 17, 2023
Molly Stoddart, RN, BSN, is a clinical research nurse on the multiple myeloma team at the Winship Cancer Institute at Emory.
Sagar Lonial, MD, FACPMyeloma | March 6, 2023
Sagar Lonial, MD, FACP, Editor-in-Chief of Blood Cancers Today, discusses Multiple Myeloma Awareness Month.
Cecilia BrownMyeloma | March 6, 2023
Dr. Raje reflects on the mentors who shaped her career, the evolution of myeloma treatment, and more.
Cecilia BrownViewpoints | February 28, 2023
Dr. Pickl discusses potential future uses and implications of a novel biomarker to predict responses to CAR-T in DLBCL.
Chadi Nabhan, MD, MBA, FACPViewpoints | February 24, 2023
Dr. Nabhan discusses his new book, "Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice."
Cecilia BrownVideo Insights | February 22, 2023
Winfried F. Pickl, MD, discusses a novel biomarker that can predict CAR-T responses in patients with DLBCL.
Cecilia BrownViewpoints | January 13, 2023
Mark Lawler, PhD, discusses insights from European Groundshot Report on survival trends and the future of cancer care.
Jennifer R. Brown, MD, PhDPrint | January 13, 2023
Jennifer R. Brown, MD, PhD, and Anthony Mato, MD, MSCE, debate combinations versus sequencing approaches in CLL.
Chadi Nabhan, MD, MBA, FACPViewpoints | January 13, 2023
As 2023 begins, you'll want to listen to The HemOnc Pulse, a new podcast that brings you the latest in hematologic oncology.
Matthew Davids, MD, MMScVideo Insights | January 9, 2023
Matthew Davids, MD, MMSc, of the Dana-Farber Cancer Institute, shares his hopes for CLL treatment and research in 2023.
Elias Jabbour, MDViewpoints | January 3, 2023
As 2022 came to a close, the Blood Cancers Today Editorial Board shared their highlights from the year.
Cecilia BrownVideo Insights | December 27, 2022
Sandy Wong, MD, of the University of California, San Francisco, shares what her hopes are in the New Year.
Amrita Krishnan, MD, FACPPrint | December 22, 2022
Amrita Krishnan, MD, FACP, and Saad Z. Usmani, MD, MBA, FACP, debate if CAR-T therapy will replace AHSCT in multiple myeloma.
Sagar Lonial, MD, FACPPrint | December 22, 2022
The past few years have been more than a challenge for those of us in health care, but we have learned many lessons.
Jerald Radich, MDViewpoints | November 23, 2022
Jerald Radich, MD; and Christopher S. Hourigan, MD, DPhil, FACP, FRCP; discuss minimal residual disease.
Leah SherwoodAcute Myeloid Leukemia | October 21, 2022
Marina Konopleva, MD, PhD, discusses venetoclax resistance in AML during SOHO 2022
Cecilia BrownAcute Myeloid Leukemia | October 13, 2022
Marina Konopleva, MD, PhD, discusses her new role at the Albert Einstein College of Medicine and highlights from her career ...
Thomas Martin, MDMyeloma | October 13, 2022
We are entering the great era of immunotherapy in multiple myeloma, as we’ve had significant...
Leah SherwoodChronic Myeloid Leukemia | September 27, 2022
International Chronic Myeloid Leukemia (CML) Day takes place on September 22.
Editorial Board